A Cross-sectional Study of COPD and Symptom Variability in MEA Countries (COPVAR)

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease

Study type

Observational

Funder types

Industry

Identifiers

NCT03425760
D2287R00105

Details and patient eligibility

About

This non-interventional study aims at assessing stable GOLD C and D COPD patient's perception of daily and weekly symptoms variability and their impact on daily activities. It will also explore the current practice in management of stable GOLD C and D COPD patients.

Full description

Primary objective: To assess perception of daily and weekly variability of symptoms in stable GOLD C and D COPD patients and their impact on daily life activities Secondary objectives: To describe the current treatment practice for the management of GOLD C and D COPD in MEA countries and their adherence to the GOLD 2015 guidelines To compare patients' perception of symptoms variability and their impact on activities between Gold categories C and D To identify demographic, behavioral and clinical factors associated with symptoms variability.

Enrollment

3,254 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients eligible for inclusion have to fulfill all of the following criteria:

    1. Stable GOLD C or D COPD patient under maintenance treatment, over 45 years, who provided signed informed consent;
    2. COPD diagnosis documented by spirometry performed in the past 12 months with an FEV1/FVC < 0.7 and an FEV1 < 50% predicted.

Exclusion criteria

Patients are not eligible for inclusion if they meet one of the following criteria:

  1. Patient with an ongoing COPD exacerbation*;
  2. Patient who has experienced an exacerbation* in the previous 3 months;
  3. History of asthma, allergic rhinitis, lung cancer or any other significant respiratory disease, such as tuberculosis, lung fibrosis or sarcoidosis;
  4. Inability to understand the study related questions;
  5. Mentally disabled patient or unable to read and write;
  6. Pregnant.
  7. Current participation in a clinical trial;

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems